Oncology Impact Fund (Cayman) Management L.P.
Insider CIK 1721036 · SNSS 10% owner · ONCR 10% owner · HARP 10% owner · TCRR 10% owner · HOWL 10% owner · CGEM 10% owner · ITOS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-04 | 2025-12-04 | 83,230 | $0.97 | $80.7K | 4,784,111 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-03 | 2025-12-04 | 57,225 | $0.87 | $49.8K | 4,867,341 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-02 | 2025-12-04 | 59,277 | $0.89 | $52.8K | 4,924,566 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-12-01 | 2025-12-01 | 60,917 | $0.94 | $57.3K | 4,983,843 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-28 | 2025-12-01 | 20,277 | $0.99 | $20.1K | 5,044,760 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-26 | 2025-12-01 | 60,733 | $0.98 | $59.5K | 5,065,037 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-25 | 2025-11-25 | 42,533 | $0.92 | $39.1K | 5,125,770 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-24 | 2025-11-25 | 88,802 | $0.98 | $87.0K | 5,168,303 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-21 | 2025-11-25 | 64,331 | $0.83 | $53.4K | 5,257,105 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-20 | 2025-11-20 | 41,152 | $0.89 | $36.6K | 5,321,436 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-19 | 2025-11-20 | 66,324 | $0.94 | $62.3K | 5,362,588 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-18 | 2025-11-20 | 52,627 | $0.93 | $48.9K | 5,428,912 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-17 | 2025-11-17 | 57,061 | $0.95 | $54.2K | 5,481,539 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-14 | 2025-11-17 | 61,640 | $0.93 | $57.3K | 5,538,600 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-13 | 2025-11-17 | 90,951 | $0.98 | $89.1K | 5,600,240 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-12 | 2025-11-12 | 40,669 | $1.09 | $44.3K | 5,691,191 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-11 | 2025-11-12 | 55,810 | $1.14 | $63.6K | 5,731,860 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-10 | 2025-11-12 | 48,570 | $1.18 | $57.3K | 5,787,670 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-07 | 2025-11-12 | 68,480 | $1.11 | $76.0K | 5,836,240 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-06 | 2025-11-06 | 54,452 | $1.21 | $65.9K | 5,904,720 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-05 | 2025-11-06 | 47,950 | $1.22 | $58.5K | 5,959,172 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-04 | 2025-11-06 | 140,488 | $1.22 | $171.4K | 6,007,122 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-11-03 | 2025-11-03 | 94,063 | $1.29 | $121.3K | 6,147,610 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-31 | 2025-11-03 | 114,044 | $1.28 | $146.0K | 6,241,673 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-30 | 2025-11-03 | 86,936 | $1.43 | $124.3K | 6,355,717 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-29 | 2025-10-29 | 134,240 | $1.55 | $208.1K | 6,442,653 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-28 | 2025-10-29 | 69,068 | $1.64 | $113.3K | 6,576,893 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-10-27 | 2025-10-29 | 72,709 | $1.72 | $125.1K | 6,645,961 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-05-13 | 2025-05-15 | 1,031,931 | $8.06 | $8.32M | 3,452,797 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 8,031 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 42,842 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise | 2025-03-27 | 2025-04-30 | 50,873 | $0.09 | $4.6K | 6,723,056 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-03-27 | 2025-04-30 | 4,386 | $1.05 | $4.6K | 6,718,670 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2023-06-01 | 2023-06-05 | 3,370,982 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 30,347 | $42.03 | $1.28M | 4,484,728 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 158,579 | $42.05 | $6.67M | 4,571,618 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 32,396 | $43.20 | $1.40M | 4,539,222 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 11,318 | $45.32 | $512.9K | 4,527,904 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 12,829 | $46.47 | $596.2K | 4,515,075 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 30,059 | $33.15 | $996.5K | 4,732,696 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 2,499 | $34.11 | $85.2K | 4,730,197 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 100 | $35.04 | $3.5K | 4,762,755 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 850 | $34.08 | $29.0K | 4,762,855 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 1,960 | $33.57 | $65.8K | 4,763,705 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 14,173 | $32.35 | $458.5K | 4,765,665 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 300 | $36.26 | $10.9K | 4,779,838 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 4,047 | $35.44 | $143.4K | 4,780,138 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 29,402 | $34.68 | $1.02M | 4,784,185 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 49,796 | $33.74 | $1.68M | 4,826,021 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 12,434 | $34.83 | $433.1K | 4,813,587 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 9,131 | $34.61 | $316.0K | 4,877,317 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 1,500 | $35.34 | $53.0K | 4,875,817 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 10,111 | $33.82 | $342.0K | 4,886,448 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 46,992 | $35.19 | $1.65M | 4,896,559 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 9,809 | $34.62 | $339.6K | 4,943,551 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 16,856 | $34.46 | $580.9K | 4,953,860 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 500 | $35.37 | $17.7K | 4,953,360 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 10,258 | $36.03 | $369.6K | 4,970,716 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 10,952 | $35.49 | $388.7K | 4,980,974 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 21,965 | $37.02 | $813.1K | 4,991,926 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 30,696 | $36.05 | $1.11M | 5,013,891 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 8,147 | $35.20 | $286.8K | 5,044,587 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 600 | $36.50 | $21.9K | 5,052,734 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 32,876 | $36.21 | $1.19M | 5,053,334 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 19,758 | $37.81 | $747.0K | 5,086,210 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 15,575 | $37.16 | $578.8K | 5,105,986 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-11-17 | 2021-11-24 | 15,671 | — | $0 | 5,121,543 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-18 | 2021-10-18 | 10,320 | $27.14 | $280.1K | 5,137,214 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 3,413 | $28.01 | $95.6K | 5,147,534 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 14,882 | $27.53 | $409.7K | 5,150,947 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-14 | 2021-10-14 | 45,719 | $27.30 | $1.25M | 5,165,829 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-13 | 2021-10-14 | 35,023 | $27.13 | $950.2K | 5,211,548 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-12 | 2021-10-14 | 14,260 | $27.09 | $386.3K | 5,246,571 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 81,684 | $27.24 | $2.23M | 5,260,831 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 3,400 | $27.01 | $91.8K | 5,342,515 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-12 | 1,922 | $27.00 | $51.9K | 5,345,915 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 34,659 | $27.06 | $937.9K | 5,347,837 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 11,471 | $27.00 | $309.7K | 5,382,496 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-30 | 2021-09-30 | 3,836 | $27.00 | $103.6K | 5,393,967 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-28 | 2021-09-30 | 32,154 | $27.00 | $868.2K | 5,397,803 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-27 | 2021-09-27 | 19,455 | $27.09 | $527.0K | 5,429,957 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-24 | 2021-09-27 | 8,221 | $27.81 | $228.6K | 5,449,412 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 60,600 | $27.96 | $1.69M | 5,458,833 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 1,200 | $28.38 | $34.1K | 5,457,633 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 23,921 | $27.54 | $658.8K | 5,519,433 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 32,858 | $27.47 | $902.6K | 5,543,354 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 17,743 | $27.03 | $479.6K | 5,599,142 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 22,930 | $27.84 | $638.4K | 5,576,212 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-17 | 2021-09-20 | 76,473 | $28.82 | $2.20M | 5,616,885 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 3,124 | $29.06 | $90.8K | 7,648,268 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 35,565 | $28.47 | $1.01M | 5,693,358 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 6,425 | $29.16 | $187.4K | 7,651,392 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 38,677 | $27.79 | $1.07M | 5,730,582 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 1,659 | $28.15 | $46.7K | 5,728,923 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 7,106 | $29.17 | $207.3K | 7,657,817 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 6,063 | $27.99 | $169.7K | 5,769,259 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 30,018 | $27.50 | $825.5K | 5,775,322 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-13 | 2021-09-13 | 3,595 | $29.10 | $104.6K | 7,664,923 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-13 | 2021-09-13 | 35,785 | $27.64 | $989.1K | 5,805,340 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 5,931 | $29.04 | $172.2K | 7,668,518 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 11,313 | $27.86 | $315.2K | 5,852,455 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 11,330 | $28.73 | $325.5K | 5,841,125 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-09 | 2021-09-13 | 13,727 | $29.35 | $402.9K | 7,674,449 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-09 | 2021-09-13 | 38,028 | $28.97 | $1.10M | 5,863,768 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 10,842 | $29.11 | $315.6K | 7,688,176 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 18,663 | $28.61 | $533.9K | 5,903,369 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 1,573 | $29.10 | $45.8K | 5,901,796 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 25,067 | $29.04 | $727.9K | 7,699,018 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 50,996 | $29.18 | $1.49M | 5,953,372 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-09-07 | 2021-09-08 | 31,340 | — | $0 | 5,922,032 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-03 | 2021-09-08 | 12,731 | $29.60 | $376.8K | 7,724,085 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-02 | 2021-09-02 | 15,757 | $29.46 | $464.2K | 7,736,816 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-09-01 | 2021-09-02 | 5,714 | $29.47 | $168.4K | 7,752,573 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-31 | 2021-09-02 | 1,285 | $29.43 | $37.8K | 7,759,840 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-31 | 2021-09-02 | 1,553 | $30.14 | $46.8K | 7,758,287 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-30 | 2021-08-31 | 31,001 | $29.30 | $908.3K | 7,761,125 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-27 | 2021-08-31 | 13,357 | $29.09 | $388.6K | 7,792,126 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-25 | 2021-08-25 | 1,713 | $29.09 | $49.8K | 7,805,483 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-24 | 2021-08-25 | 50,822 | $29.48 | $1.50M | 7,807,196 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-23 | 2021-08-25 | 53,359 | $29.11 | $1.55M | 7,858,018 | SEC↗ |
| CGEM Cullinan Oncology, Inc. | S Sale | 2021-08-11 | 2021-08-12 | 2,510 | $29.05 | $72.9K | 7,911,377 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 25,118 | $20.50 | $514.9K | 6,328,095 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 18,491 | $20.44 | $378.0K | 6,353,213 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 100 | $22.60 | $2.3K | 6,371,704 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 3,100 | $21.92 | $68.0K | 6,371,804 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-28 | 2021-06-02 | 10,685 | $20.88 | $223.1K | 6,374,904 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-27 | 2021-05-27 | 13,961 | $20.26 | $282.8K | 6,385,589 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-26 | 2021-05-27 | 3,198 | $20.04 | $64.1K | 6,399,550 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-24 | 2021-05-24 | 5,000 | $20.12 | $100.6K | 6,402,748 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-21 | 2021-05-24 | 10,907 | $20.21 | $220.4K | 6,407,748 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-20 | 2021-05-20 | 11,713 | $20.34 | $238.2K | 6,418,655 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-19 | 2021-05-20 | 17,833 | $20.39 | $363.6K | 6,430,368 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-18 | 2021-05-20 | 18,402 | $20.67 | $380.4K | 6,448,201 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-17 | 2021-05-17 | 4,666 | $20.07 | $93.6K | 6,466,603 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-14 | 2021-05-17 | 6,900 | $20.04 | $138.3K | 6,471,269 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-13 | 2021-05-17 | 4,855 | $20.06 | $97.4K | 6,478,169 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-12 | 29,684 | $20.53 | $609.4K | 6,483,024 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-12 | 7,672 | $21.51 | $165.0K | 6,512,708 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-12 | 13,773 | $20.96 | $288.7K | 6,520,380 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-12 | 16,722 | $21.78 | $364.2K | 6,534,564 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-10 | 2021-05-12 | 411 | $22.46 | $9.2K | 6,534,153 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-06 | 59 | $23.09 | $1.4K | 6,551,286 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-05 | 2021-05-06 | 10,113 | $22.52 | $227.7K | 6,551,345 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 38,817,998 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 12,899,925 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 26,230 | $23.03 | $604.1K | 6,564,958 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 3,500 | $23.33 | $81.7K | 6,561,458 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | P Buy | 2021-05-04 | 2021-05-06 | 245,000 | $16.00 | $3.92M | 6,672,183 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 1,488,033 | — | $0 | 6,427,183 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 4,477,742 | — | $0 | 4,939,150 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 4,401 | $23.45 | $103.2K | 6,591,188 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 26,365 | $23.03 | $607.2K | 6,595,589 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-30 | 2021-05-04 | 268,023 | $22.35 | $5.99M | 6,621,954 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-29 | 2021-04-29 | 45,511 | $22.02 | $1.00M | 6,911,758 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-29 | 2021-04-29 | 21,781 | $22.54 | $490.9K | 6,889,977 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-28 | 2021-04-29 | 14,219 | $21.64 | $307.7K | 6,994,072 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-28 | 2021-04-29 | 36,803 | $22.01 | $810.0K | 6,957,269 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-27 | 2021-04-29 | 8,328 | $21.26 | $177.1K | 7,008,291 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-27 | 2021-04-29 | 3,501 | $20.99 | $73.5K | 7,016,619 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-21 | 2021-04-22 | 555 | $19.48 | $10.8K | 7,020,120 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-21 | 2021-04-22 | 8,417 | $18.94 | $159.4K | 7,020,675 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-20 | 2021-04-20 | 834 | $19.09 | $15.9K | 7,029,092 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-20 | 2021-04-20 | 21,415 | $18.70 | $400.5K | 7,029,926 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-19 | 2021-04-20 | 9,956 | $19.29 | $192.1K | 7,051,441 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-19 | 2021-04-20 | 100 | $20.08 | $2.0K | 7,051,341 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-16 | 2021-04-20 | 300 | $20.56 | $6.2K | 7,061,397 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-16 | 2021-04-20 | 5,547 | $19.82 | $109.9K | 7,061,697 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-15 | 2021-04-15 | 8,696 | $20.49 | $178.2K | 7,067,244 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 12,806 | $20.83 | $266.7K | 7,075,940 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 1,000 | $20.06 | $20.1K | 7,088,746 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 13,692 | $19.35 | $264.9K | 7,092,108 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 2,362 | $20.08 | $47.4K | 7,089,746 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 13,528 | $20.72 | $280.3K | 7,112,900 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 6,700 | $21.52 | $144.2K | 7,106,200 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 400 | $22.68 | $9.1K | 7,105,800 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 10,300 | $23.67 | $243.8K | 7,126,428 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 200 | $29.99 | $6.0K | 6,004,368 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 31,890 | $30.51 | $973.0K | 6,004,982 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 414 | $31.01 | $12.8K | 6,004,568 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 1,300 | $33.84 | $44.0K | 6,052,542 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-04-07 | 2021-04-09 | 15,670 | — | $0 | 6,036,872 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 3,083 | $32.84 | $101.2K | 6,053,842 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 5,295 | $32.07 | $169.8K | 6,056,925 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 2,276,692 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 649,030 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 1,136,525 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion deriv | 2021-01-12 | 2021-01-14 | 3,551,640 | — | $0 | 0 | SEC↗ |
| CGEM Cullinan Management, Inc. | P Buy | 2021-01-12 | 2021-01-14 | 300,000 | $21.00 | $6.30M | 7,913,887 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 649,030 | — | $0 | 7,613,887 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 1,136,525 | — | $0 | 1,136,525 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 3,551,640 | — | $0 | 4,688,165 | SEC↗ |
| CGEM Cullinan Management, Inc. | C Conversion | 2021-01-12 | 2021-01-14 | 2,276,692 | — | $0 | 6,964,857 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 2,225,801 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 151,224 | $15.00 | $2.27M | 2,377,025 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 1,525,348 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 4,211,330 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 3,824,591 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 255,094 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 131,645 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,600,628 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 29,440 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 79,281 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 1,491,666 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 81,295 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 157,529 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,361,805 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 47,674 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 128,384 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,415,530 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 1,121 | $19.00 | $21.3K | 25,974 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 56,814 | $19.00 | $1.08M | 1,316,139 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 24,326 | — | $0 | 66,931 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 457,706 | — | $0 | 1,259,325 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 24,944 | — | $0 | 68,381 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 48,336 | — | $0 | 132,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 724,702 | — | $0 | 1,993,932 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,397,574 | — | $0 | 1,397,574 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 15,820 | — | $0 | 15,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 42,605 | — | $0 | 42,605 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 801,619 | — | $0 | 801,619 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 43,687 | — | $0 | 43,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 9,033 | — | $0 | 24,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 797,983 | — | $0 | 2,195,557 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 89,955 | $19.00 | $1.71M | 2,083,887 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 5,994 | $19.00 | $113.9K | 138,985 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 84,655 | — | $0 | 84,655 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 1,269,230 | — | $0 | 1,269,230 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 160,000 | $19.00 | $3.04M | 2,355,557 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 3,096 | $19.00 | $58.8K | 71,727 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 3,020 | $19.00 | $57.4K | 69,951 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 15,000,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 1,750,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 2,421,775 | — | $0 | 2,421,775 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 282,540 | — | $0 | 2,704,315 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | P Buy | 2019-02-19 | 2019-02-21 | 666,667 | $15.00 | $10.00M | 3,370,982 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 417,853 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,525,165 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 76,258 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-14 | 1,578,755 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise deriv | 2019-02-12 | 2019-02-14 | 50,838 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,525,165 | — | $0 | 1,525,165 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 1,578,755 | — | $0 | 3,103,920 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | C Conversion | 2019-02-12 | 2019-02-14 | 417,853 | — | $0 | 3,521,773 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | X Exercise | 2019-02-12 | 2019-02-14 | 127,096 | $0.05 | $6.4K | 3,648,869 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2019-02-12 | 2019-02-14 | 447 | $14.00 | $6.3K | 3,648,422 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | P Buy | 2019-02-12 | 2019-02-14 | 250,000 | $14.00 | $3.50M | 3,898,422 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-06 | 2017-11-06 | 16,200 | $2.77 | $44.9K | 3,331,500 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-03 | 2017-11-06 | 40,000 | $2.89 | $115.6K | 3,315,300 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | P Buy | 2017-11-02 | 2017-11-06 | 25,300 | $2.59 | $65.5K | 3,275,300 | SEC↗ |